Page last updated: 2024-09-03

4-s-(propionic acid)sulfidocyclophosphamide and Cardiac Failure

4-s-(propionic acid)sulfidocyclophosphamide has been researched along with Cardiac Failure in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Braun-Dullaeus, RC; Groscheck, T; Hansen, M; Kropf, S; Luani, B; Meißler, S; Rauwolf, T; Schmeisser, A; Steendijk, P; Tanev, I1

Trials

1 trial(s) available for 4-s-(propionic acid)sulfidocyclophosphamide and Cardiac Failure

ArticleYear
Pressure-volume loop validation of TAPSE/PASP for right ventricular arterial coupling in heart failure with pulmonary hypertension.
    European heart journal. Cardiovascular Imaging, 2021, 01-22, Volume: 22, Issue:2

    Topics: Cyclophosphamide; Heart Failure; Humans; Hypertension, Pulmonary; Pulmonary Artery; Stroke Volume; Ventricular Dysfunction, Right; Ventricular Function, Right

2021